Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02052024 · ClinicalTrials.gov registry record · Phase 4
Myobloc Atrophy Study
A Phase 4 study, sponsored by Georgetown University.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT02052024 is a Phase 4 study that has completed, run by Georgetown University. The registered enrollment target is 10 participants.
The verdict
NCT02052024, a Phase 4 study, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
The present pilot study is designed to assess the extent to which BOTOX and MYOBLOC cause muscle atrophy in spastic patients. The primary objective is to assess whether there is statistically significant difference in muscle atrophy between the two groups over a one year period.
Interventions
- DRUG MYOBLOC
- DRUG Botox
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-05 |
| Est. Completion | 2015-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02052024
The ClinicalTrials.gov registry entry for NCT02052024 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MYOBLOC is the first listed.
NCT02052024 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02052024 about?
NCT02052024 is a clinical study titled "Myobloc Atrophy Study". The present pilot study is designed to assess the extent to which BOTOX and MYOBLOC cause muscle atrophy in spastic patients. The primary objective is to assess whether there is statistically significant difference in muscle atrophy between the two groups over a one year period.
What is the current status of trial NCT02052024?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2014-05. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02052024?
The interventions under investigation include: MYOBLOC (DRUG), Botox (DRUG).
Who is sponsoring clinical trial NCT02052024?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.